| Literature DB >> 15346250 |
Michael Charlton1, Russell Wiesner.
Abstract
With almost universal virological recurrence and a projected several-fold increase in HCV-related end-stage liver disease within the next decade, a clear understanding of the natural history of posttransplant HCV infection and optimization of the management of recurrent HCV infection are imperative. This article describes the natural history, risk factors, and current strategies for the amelioration of posttransplant HCV infection.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15346250 DOI: 10.1055/s-2004-832932
Source DB: PubMed Journal: Semin Liver Dis ISSN: 0272-8087 Impact factor: 6.115